The dominant‐negative effects of SPOP mutant proteins on different substrate proteins may correspond to the occurrence and progression of endometrial and prostate cancers (Baca et al., 2013; Barbieri et al., 2012; Janouskova et al., 2017; Le Gallo et al., 2012). This evidence concerns the gene SPOP and prostate carcinoma.